Cargando…

Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders

B-cell chronic lymphoproliferative disorders (B-CLPD) comprise several entities with indolent clinical manifestations but heterogeneous survival. Cytogenetic aberrations are now the standard prognostic predictors in chronic lymphocytic leukemia (CLL) but have been less investigated in other subtypes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Shuhua, Li, Zengjun, Zou, Dehui, Xiong, Wenjie, Li, Heng, Cui, Rui, Li, Chengwen, Yan, Yuting, Liu, Wei, Lv, Rui, Yu, Zhen, Chen, Weiwei, Xu, Yan, An, Gang, Wang, Huijun, Ru, Kun, Cheng, Tao, Wang, Jianxiang, Qiu, Lugui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790468/ https://www.ncbi.nlm.nih.gov/pubmed/29423051 http://dx.doi.org/10.18632/oncotarget.23261

Ejemplares similares

Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
por: Yi, Shuhua, et al.
Publicado: (2020)

Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China
por: Yan, Yuting, et al.
Publicado: (2023)

BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase
por: Zou, Dehui, et al.
Publicado: (2017)

High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival
por: Yi, Shuhua, et al.
Publicado: (2015)

Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma
por: Li, Ru, et al.
Publicado: (2022)

Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China
por: Li, Heng, et al.
Publicado: (2017)

Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region
por: Yi, Shuhua, et al.
Publicado: (2017)

MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma
por: Li, Fei, et al.
Publicado: (2015)

Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM
por: Wang, Jun, et al.
Publicado: (2022)

Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia
por: Xiong, Wenjie, et al.
Publicado: (2023)

Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients
por: Xiong, Wenjie, et al.
Publicado: (2023)

Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma
por: Li, Fei, et al.
Publicado: (2015)

Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China
por: Li, Zengjun, et al.
Publicado: (2015)

Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis
por: Hao, Mu, et al.
Publicado: (2016)

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma
por: Yi, Shuhua, et al.
Publicado: (2022)

Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH
por: Zang, Meirong, et al.
Publicado: (2015)

Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
por: Liu, Jiahui, et al.
Publicado: (2023)

Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia
por: Sun, Hao, et al.
Publicado: (2022)

Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3)
por: Jia, Yannan, et al.
Publicado: (2022)

Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells
por: Hao, Mu, et al.
Publicado: (2011)

P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA
por: Zou, Hesong, et al.
Publicado: (2023)

Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease
por: Zhu, Jia, et al.
Publicado: (2013)

Keratin 17 is Not Always a Marker of Proliferation of Keratinocytes in Skin Diseases
por: Cui, Li, et al.
Publicado: (2021)

The potential differential diagnosis value and clinical significance of CD35 expression in B-chronic lymphoproliferative disorders
por: Shi, Yu, et al.
Publicado: (2021)

Treatment Advances in EBV Related Lymphoproliferative Diseases
por: Lv, Kebing, et al.
Publicado: (2022)

Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH
por: Yan, Yuting, et al.
Publicado: (2022)

Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
por: Yan, Wenqiang, et al.
Publicado: (2023)

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
por: Gu, Runxia, et al.
Publicado: (2020)

Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment
por: Li, Sidan, et al.
Publicado: (2015)

Establishment of a combination scoring method for diagnosis of ocular adnexal lymphoproliferative disease
por: Qu, Xiao-Li, et al.
Publicado: (2017)

Sinonasal/nasopharyngeal pleomorphic adenoma and carcinoma ex pleomorphic adenoma: a report of 17 surgical cases combined with a literature review
por: Li, Wanpeng, et al.
Publicado: (2019)

CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature
por: Weng, Chun-Yan, et al.
Publicado: (2022)

Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder
por: Yiğit Kaya, Süreyya, et al.
Publicado: (2023)

The Influence of a Memory Delay on Spatial Coding in the Superior Colliculus: Is Visual Always Visual and Motor Always Motor?
por: Sadeh, Morteza, et al.
Publicado: (2018)

Expression and clinical significance of matrix metalloproteinase-17 and -25 in gastric cancer
por: WANG, YING, et al.
Publicado: (2015)

Hydroa vacciniforme‐like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China
por: Wang, Xinhua, et al.
Publicado: (2021)

Fluorescence in situ hybridization (FISH) in imprint of biopsies suspected of lymphoproliferative neoplasms: report on 17 cases
por: Safranauskas, Roberta Maria da Silva Oliveira, et al.
Publicado: (2023)

Malignant Lymphoproliferative Diseases
por: Garrett, J. V.
Publicado: (1981)

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Cardiovascular and Lymphoproliferative Diseases
por: Huston, Sharon M., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_57f5tsdlo3mdubtlh04ibj53kh